Express Scripts bars 48 drugs for 2019, hitting AbbVie, Gilead, Boehringer and more It’s that time of year again—the time when lead pharmacy benefits manager Express Scripts ignites pharma’s ire […]
With patisiran launch in its sights, Alnylam plots a major hiring spree Alnylam’s first drug approval could come any day now, and the company is bulking up to get ready—in […]
FDA notes Paratek antibiotic’s noninferiority as it heads to AdComm vote Paratek Pharmaceuticals’ first drug, and the first in a new class of broad-spectrum antibiotics called aminomethylcyclines, has shown to […]
Akouos raises M to take hearing loss gene therapy into humans Akouos has raised $50 million to take a gene therapy treatment for hearing loss into the clinic. The Boston-based […]
Ironwood abandons deal with AstraZeneca for lesinurad, once hoped to be a gout blockbuster Ironwood Pharmaceuticals has decided to walk away from its 2016 deal to license AstraZeneca’s billion-dollar gout […]